Literature DB >> 3918270

Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester.

A Truneh, F Albert, P Golstein, A M Schmitt-Verhulst.   

Abstract

Although it has been proposed that the activation of T lymphocytes is mediated by an early rise in cytosolic calcium concentration, it has not been possible to mimic antigen- or mitogen-induced mouse lymphocyte activation by calcium ionophores that bypass receptor-mediated processes. There is now evidence from other systems that the rise in cytosolic calcium which follows receptor triggering is preceded by the breakdown of phosphatidylinositol bisphosphate into 1,2-diacylglycerol and inositol trisphosphate. The latter is known to cause release of calcium from intracellular stores. The cellular target for the former is now widely accepted to be protein kinase C. Therefore, ligand-induced cellular response follows a rise in cytosolic calcium concentration and protein kinase C activation. Here we confirm that the calcium ionophores A23187 and ionomycin do not activate mouse T lymphocytes. However, either one in combination with the phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA), which is structurally related to 1,2-diacylglycerol, induces in lymphoid cell populations the expression of receptors for interleukin-2 (IL-2), the secretion of IL-2 and cell proliferation as measured by 3H-thymidine uptake. The growth-promoting effect of IL-2 on an exogenous IL-2-dependent clone could not be substituted for by ionomycin either alone or with TPA. Thus, the combination of calcium ionophores and TPA bypasses the requirement for antigen- or lectin-induced signal at the onset of lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918270     DOI: 10.1038/313318a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  173 in total

1.  Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation.

Authors:  S Miyamoto; B Safer
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

2.  Transcriptional activation of the human cytotoxic serine protease gene CSP-B in T lymphocytes.

Authors:  R D Hanson; T J Ley
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

3.  CD3 and CD2 antigen-mediated CD3 gamma-chain phosphorylation in permeabilized human T cells. Regulation by cytosolic phosphatases.

Authors:  D R Alexander; M H Brown; A L Tutt; M J Crumpton; E Shivnan
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

4.  Susceptibility to cell death is a dominant phenotype: triggering of activation-driven T-cell death independent of the T-cell antigen receptor complex.

Authors:  G Nickas; J Meyers; L D Hebshi; J D Ashwell; D P Gold; B Sydora; D S Ucker
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

5.  Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells.

Authors:  Sheri Tinnell Dorsam; Emilie Vomhof-Dekrey; Rebecca J Hermann; Jodie S Haring; Travis Van der Steen; Erich Wilkerson; Goran Boskovic; James Denvir; Yulia Dementieva; Donald Primerano; Glenn Paul Dorsam
Journal:  Mol Immunol       Date:  2010-02-01       Impact factor: 4.407

6.  Regulation of interleukin 3 gene induction in normal human T cells.

Authors:  S C Guba; G Stella; L A Turka; C H June; C B Thompson; S G Emerson
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Proliferation in vitro of Lyt2-,L3T4- thymocytes shows responsiveness to interleukin 1.

Authors:  G Chaudhri; I A Clark; R Ceredig
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

8.  Activation and proliferation signals in mouse B cells. IX. Protein kinase C activators synergize with non-mitogenic anti-immunoglobulin antibodies to drive B cells into G1.

Authors:  M K Bijsterbosch; J B McLaughlin; M Holman; G G Klaus
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

9.  TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.

Authors:  Ramireddy Bommireddy; Ilona Ormsby; Moying Yin; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

10.  Modulation of the IL-2 production defect in vitro in Graves' disease.

Authors:  Z Eisenstein; E Engelsman; M Weiss; Y Kalechman; B Sredni
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.